Short description
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
Description
Exai Bio is a next-generation liquid biopsy company. Exai bio proprietary RNA and artificial intelligence-based liquid biopsy platform deliver clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Palo Alto, California, United States, North America
Founded on
January 1, 2021
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
Uh Ohhhh, Blurry Noaccess, Nopepepe
Sign in for full access
Founders
Babak Alipanahi, Pat Arensdorf